Filtros

Buscador
Año
Rios A, Torregrosa B, Rodríguez JM, Rodríguez D, Cepero A, Abellán MD, Torregrosa NM, Hernández AM, Parrilla P. Ultrasonographic risk factors of malignancy in thyroid nodules. Langenbecks Arch Surg. 2016 Sep;401(6):839-49. doi: 10.1007/s00423-016-1451-y. Epub 2016 Jun 4. PubMed PMID: 27263038.
AÑO: 2016; IF: 2.203
Autores:
Ríos A, Rodríguez JM, Torregrosa NM, Torregrosa B, Cepero A, Abellán MD, Hernández AM, Parrilla P. Evaluation of the thyroid nodule with high-resolution ultrasonography and elastography without fine needle aspiration biopsy. Med Clin (Barc). 2018 Aug 10;151(3):89-96. doi: 10.1016/j.medcli.2017.09.016. Epub 2017 Oct 31. English, Spanish. PubMed PMID: 29096966.
AÑO: 2018; IF: 1.277
Autores:
Piñero A, Hernández A, Rodríguez JM, Parrilla P. [Clinical remission and reduction of malignant pheochromocytoma treated with iodine-131-meta-iodobenzylguanidine]. Med Clin (Barc). 1996 Nov 30;107(19):755-6. Spanish. PubMed PMID: 9082096.
AÑO: 1996; IF: 1.168
Caixàs A, Bernà L, Hernández A, Tébar FJ, Madariaga P, Vegazo O, Bittini AL, Moreno B, Faure E, Abós D, Piera J, Rodríguez JM, Farrerons J, Puig-Domingo M. Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surgery. 1997 May;121(5):535-41. PubMed PMID: 9142152.
AÑO: 1997; IF: 3.574
Autores:
Pomares FJ, Cañas R, Rodriguez JM, Hernandez AM, Parrilla P, Tebar FJ. Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. Clin Endocrinol (Oxf). 1998 Feb;48(2):195-200. PubMed PMID: 9579232.
AÑO: 1998; IF: 3.077